中国伤残医学
中國傷殘醫學
중국상잔의학
CHINESE JOURNAL OF TRAUMA AND DISABILITY MEDICINE
2013年
11期
19-20
,共2页
晚期肝癌%肝硬化%复方甘草酸苷注射液%斑蝥酸钠维生素B6 注射液
晚期肝癌%肝硬化%複方甘草痠苷註射液%斑蝥痠鈉維生素B6 註射液
만기간암%간경화%복방감초산감주사액%반모산납유생소B6 주사액
Glycyrrhizin Injection%Disodium Cantharidinate%Vitamin B6%Hepatocellular Carcinoma%Cirrhosisusing
目的:对晚期肝癌并发肝硬化患者采用复方甘草酸苷注射液联合斑蝥酸钠维生素B6注射液进行治疗,对其疗效进行观察和分析。方法:对我院收治的168例晚期肝癌并发肝硬化患者进行随机分组,分成试验组和对照组,分别为84例。对照组:对患者使用斑蝥酸钠维生素B6进行治疗。试验组:在对照组的基础上,对患者加用复方甘草酸苷注射液进行治疗。对2组患者都进行抗肿瘤、保肝和对症治疗。结果:试验组患者的生化指标改善和转阴率要明显优于对照组,差异显著,具有统计学意义(P<0.05)。2组患者没有出现明显性的不良反应。结论:对晚期肝癌并发肝硬化患者采用复方甘草酸苷注射液联合斑蝥酸钠维生素B6注射液进行治疗,效果显著,并且不良反应少,值得在临床上进行推广和应用。
目的:對晚期肝癌併髮肝硬化患者採用複方甘草痠苷註射液聯閤斑蝥痠鈉維生素B6註射液進行治療,對其療效進行觀察和分析。方法:對我院收治的168例晚期肝癌併髮肝硬化患者進行隨機分組,分成試驗組和對照組,分彆為84例。對照組:對患者使用斑蝥痠鈉維生素B6進行治療。試驗組:在對照組的基礎上,對患者加用複方甘草痠苷註射液進行治療。對2組患者都進行抗腫瘤、保肝和對癥治療。結果:試驗組患者的生化指標改善和轉陰率要明顯優于對照組,差異顯著,具有統計學意義(P<0.05)。2組患者沒有齣現明顯性的不良反應。結論:對晚期肝癌併髮肝硬化患者採用複方甘草痠苷註射液聯閤斑蝥痠鈉維生素B6註射液進行治療,效果顯著,併且不良反應少,值得在臨床上進行推廣和應用。
목적:대만기간암병발간경화환자채용복방감초산감주사액연합반모산납유생소B6주사액진행치료,대기료효진행관찰화분석。방법:대아원수치적168례만기간암병발간경화환자진행수궤분조,분성시험조화대조조,분별위84례。대조조:대환자사용반모산납유생소B6진행치료。시험조:재대조조적기출상,대환자가용복방감초산감주사액진행치료。대2조환자도진행항종류、보간화대증치료。결과:시험조환자적생화지표개선화전음솔요명현우우대조조,차이현저,구유통계학의의(P<0.05)。2조환자몰유출현명현성적불량반응。결론:대만기간암병발간경화환자채용복방감초산감주사액연합반모산납유생소B6주사액진행치료,효과현저,병차불량반응소,치득재림상상진행추엄화응용。
objective:to treat patients with advanced hepatocellular carcinoma with cirrhosisusing compound glycyrrhizin injection combined with disodium cantharidinate and vitamin B 6 injection, observe and analyze its curative effect .Methods:our hospital 168 cases of advanced hepatocellular carcinoma complicated with liver cirrhosis were randomly divided into groups , divided into experimental and control groups, respectively 84cases.Control group:the patients using sodium cantharidate vitamin B 6treatment.Experimental group: in the control group on the basis of patients , combined with compound Glycyrrhizin Injection treatment .On two groups of patients were tumor,liver and symptomatic treatment .Results:Patients with biochemical marker sand negative rate to be significantly better than the control group, the difference was significant, with statistical significance(P<0.05).Two groups of patients with no adverse events .Con-clusion:for patients with advanced hepatocellular carcinomawith cirrhosisusing compound glycyrrhizin injection combined with disodium cantharidinate and vitamin B 6 injection treatment, significant effect , and less adverse reactions , it is worthy of promotion and application in clinical .